IMMUNOPRECISE ANTIBODIES LTD (IPA)

CA45257F2008 - Common Stock

1.23  +0.05 (+4.24%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-1-31)
2023
(2023-4-30)
2022
(2022-4-30)
2021
(2021-4-30)
2020
(2020-4-30)
Revenue
23.68M20.66M19.36M17.91M14.06M
Cost Of Goods
11.39M9.10M8.38M6.37M6.02M
Gross Profit
12.29M11.56M10.98M11.54M8.03M
Operating Expenses
28.90M40.11M27.23M18.46M12.13M
Research and Development
3.62M12.28M6.69M1.97M446.00K
Selling, General, and Administrative Expenses
21.70M23.42M17.97M13.75M9.11M
Operating Income
-16.62M-28.55M-16.24M-6.92M-4.09M
Interest Income/Expense
560.00K494.00K487.00K-1.59M-353.00K
Other Income/Expense
310.00K332.00KN/AN/AN/A
Non Recurring Items
N/A-27.00K-92.00K2.52M-845.00K
Income Before Taxes
-15.78M-27.75M-15.85M-6.00M-5.29M
Income Tax
-1.51M-1.19M861.00K1.34M-346.00K
Net Income
-14.26M-26.56M-16.71M-7.34M-4.95M
EBITDA
-10.48M-21.87M-12.47M-3.21M-686.70K
 
Per Share Data
EPS Diluted Total Ops
-0.55-1.07-0.85-0.45-0.36
Non GAAP EPS
-0.56N/AN/AN/AN/A
 
Statistics
Gross Profit Margin
51.88%55.95%56.72%64.41%57.15%
Profit Margin
-60.23%-128.53%-86.29%-40.98%-35.19%
Operating Profit Margin
-70.18%-138.16%-83.88%-38.63%-29.13%

All data in CAD

Charts